Literature DB >> 32340093

[Investigation on a cluster epidemic of COVID-19 in a supermarket in Liaocheng, Shandong province].

J Z Zhang1, P Zhou1, D B Han1, W C Wang1, C Cui1, R Zhou1, K X Xu1, L Liu1, X H Wang2, X H Bai2, X K Jiang1.   

Abstract

Objective: To explore clustered epidemic of COVID-19 in Liaocheng city and analyze infection status and chain of transmission of the cases.
Methods: A joint investigation team of emergency response for COVID-19 epidemic by CDC professional workers of Liaocheng city and district at two levels on January 30, 2020. According to a indicator case from ZH supermarkets, close contacts and related subjects were tracked and screened on February 1, including ZH supermarket employees, family members having contact history with related cases during January 13-26, supermarket clients during January 16-30 and family members of related cases. an epidemiological investigation was carried on and their swab of nose /throat were collected and were sent to Liaocheng CDC laboratory, real-time fluorescence quantitative RT-PCR was used to detect nucleic acids of SARS-CoV-2.
Results: a total of 8 437 people were screened during January 30 to February 9, 2020 (120 employees of supermarket, 93 family members, and 8224 clients of supermarket). The epidemic was caused by ZH cases and brought clustered cases in four families. A total 25 cases of SARS-CoV-2 infection, the total infection rate of subjects was 0.30% (25/8 437) with 22 confirmed cases (0.26%, 22/8 437) and 3 asymptomatic patients (0.04%, 3/8 437), asymptomatic patients accounted for 12.00% (3/25) of all infection cases. The infection rates of supermarket employees, family members of confirmed cases and supermarket clients were 9.17% (11/120), 12.90% (12/93) and 0.02% (2/8 224). Conclusions: This was a cluster epidemic caused by one imported case of COVID-19 in a supermarket of Liaocheng city. Prevention and control of cluster epidemic should be focused on chain of community transmission and family cluster cases. It must also be an attention for transmission risk of asymptomatic patients.

Entities:  

Keywords:  Asymptomatic patient; COVID-19; Cluster epidemic; Community transmission; Imported case

Year:  2020        PMID: 32340093     DOI: 10.3760/cma.j.cn112338-20200228-00206

Source DB:  PubMed          Journal:  Zhonghua Liu Xing Bing Xue Za Zhi        ISSN: 0254-6450


  15 in total

1.  Essential but Ill-Prepared: How the COVID-19 Pandemic Affects the Mental Health of the Grocery Store Workforce.

Authors:  Brian Mayer; Mona Arora; Sabrina Helm; Melissa Barnett
Journal:  Public Health Rep       Date:  2021-09-15       Impact factor: 2.792

2.  What do we know about SARS-CoV-2 transmission? A systematic review and meta-analysis of the secondary attack rate and associated risk factors.

Authors:  Wee Chian Koh; Lin Naing; Liling Chaw; Muhammad Ali Rosledzana; Mohammad Fathi Alikhan; Sirajul Adli Jamaludin; Faezah Amin; Asiah Omar; Alia Shazli; Matthew Griffith; Roberta Pastore; Justin Wong
Journal:  PLoS One       Date:  2020-10-08       Impact factor: 3.240

3.  Household Transmission of SARS-CoV-2: A Systematic Review and Meta-analysis.

Authors:  Zachary J Madewell; Yang Yang; Ira M Longini; M Elizabeth Halloran; Natalie E Dean
Journal:  JAMA Netw Open       Date:  2020-12-01

4.  The role of asymptomatic and pre-symptomatic infection in SARS-CoV-2 transmission-a living systematic review.

Authors:  Xueting Qiu; Ali Ihsan Nergiz; Alberto Enrico Maraolo; Isaac I Bogoch; Nicola Low; Muge Cevik
Journal:  Clin Microbiol Infect       Date:  2021-01-21       Impact factor: 8.067

Review 5.  How to detect and reduce potential sources of biases in studies of SARS-CoV-2 and COVID-19.

Authors:  Emma K Accorsi; Xueting Qiu; Eva Rumpler; Lee Kennedy-Shaffer; Rebecca Kahn; Keya Joshi; Edward Goldstein; Mats J Stensrud; Rene Niehus; Muge Cevik; Marc Lipsitch
Journal:  Eur J Epidemiol       Date:  2021-02-25       Impact factor: 8.082

6.  SARS-CoV-2 routes of transmission and recommendations for preventing acquisition: joint British Infection Association (BIA), Healthcare Infection Society (HIS), Infection Prevention Society (IPS) and Royal College of Pathologists (RCPath) guidance.

Authors:  A Bak; M A Mugglestone; N V Ratnaraja; J A Wilson; L Rivett; S M Stoneham; J Bostock; S E Moses; J R Price; M Weinbren; H P Loveday; J Islam; A P R Wilson
Journal:  J Hosp Infect       Date:  2021-05-01       Impact factor: 3.926

7.  Seroprevalence of SARS-CoV-2 Antibodies in Symptomatic Individuals Is Higher than in Persons Who Are at Increased Risk Exposure: The Results of the Single-Center, Prospective, Cross-Sectional Study.

Authors:  Alexandr Zurochka; Maria Dobrinina; Vladimir Zurochka; Desheng Hu; Alexandr Solovyev; Liana Ryabova; Igor Kritsky; Roman Ibragimov; Alexey Sarapultsev
Journal:  Vaccines (Basel)       Date:  2021-06-09

8.  Household transmission of SARS-CoV-2: a systematic review and meta-analysis of secondary attack rate.

Authors:  Zachary J Madewell; Yang Yang; Ira M Longini; M Elizabeth Halloran; Natalie E Dean
Journal:  medRxiv       Date:  2020-07-31

9.  When cancer encounters COVID-19 in China: what have we suffered, experienced and learned.

Authors:  Haiyang Chen; Xuan Wu; Wei Wang; Qiming Wang
Journal:  Jpn J Clin Oncol       Date:  2020-06-10       Impact factor: 3.019

10.  Proportion of asymptomatic infection among COVID-19 positive persons and their transmission potential: A systematic review and meta-analysis.

Authors:  Mercedes Yanes-Lane; Nicholas Winters; Federica Fregonese; Mayara Bastos; Sara Perlman-Arrow; Jonathon R Campbell; Dick Menzies
Journal:  PLoS One       Date:  2020-11-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.